Global Genotyping Market Size, Share, and Growth & Trends Analysis By Product (Instruments, Reagents & Kits, Software and Services) By Technology (PCR, Capillary, Electrophoresis, Microarrays, Sequencing, Mass Spectrometry, Others) By Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Agricultural Biotechnology, Animal Genetics, Others) By End Use (Pharmaceutical and Biopharmaceutical Companies, Diagnostics and Research Laboratories, Academic Institutes, Others) By Region (North America, Asia Pacific, Europe, Middle East & Africa, South America): Regional Outlook, Growth Potential and Segments Forecast 2024-2031

Loading...

Budget constraints? Get in touch with us for special pricing

Buying Options

Original price was: $6,000.00.Current price is: $5,100.00.
Original price was: $5,000.00.Current price is: $4,500.00.
Original price was: $4,000.00.Current price is: $3,800.00.
Loading...

Description

The Global Genotyping Market size was USD 15.09 billion in 2023 and is projected to reach USD 28.2 billion by 2031, with a CAGR of 14.59 % during the forecast period. 

Global Genotyping Market: Overview

The genotyping market continues to grow rapidly, owing to a number of important innovations and advancements. The growing use of next-generation sequencing (NGS) technology is an important contributor, as NGS platforms allow for a high-through, complete investigation of variations in genes, resulting in deeper genetic insights. The lowering cost of DNA sequencing, combined with the increasing demand for precision medicine, fuels this trend. At the same time, advances in PCR-based genotyping, notably actual time and digital PCR, have boosted the speed, accuracy, and sensitivity of genotyping, widening its usage in research, examinations, and healthcare environments. Another key breakthrough is the integration of genotype data with informatics and sophisticated data analytics, which enables efficient data management and valuable insights extraction for applications in personalised medicine and pharmacogenomics. In addition, the application range of sequencing is expanding into agrigenomics, animal genetics, forensics, and environmental testing due to the growing importance of genetic analysis in these areas. Strategic collaborations and partnerships among leading market players are also accelerating innovation, enhancing product portfolios, and expanding geographic reach. In summary, the genotyping market is witnessing significant technological and analytical advancements, driving its growth and adoption across various sectors.

Global Genotyping Market: Covid-19 Impact

The COVID-19 epidemic has had an enormous effect on the Dark Fibre market, resulting both as obstacles and possibilities. With the rising need for high-speed internet access resulting from remote work and surfing the web, the creation of dark fibre networks has been on the rise. However, logistical interruptions and economic uncertainty have also caused difficulties. Overall, the market is seeing changes in patterns of consumption and strategic investments to adapt to the new state of affairs.

Global Genotyping Market: Growth Drivers

  • Technological Advancements:

Continuous advancements in genotyping technologies, such as next-generation sequencing (NGS), CRISPR, and high-throughput genotyping, are significantly driving market growth. These technologies offer greater accuracy, speed, and cost-efficiency, making genotyping more accessible and applicable in various fields, including medical research, agriculture, and pharmacogenomics.

  • Increasing Prevalence of Genetic Disorders:

The rising incidence of genetic disorders and the growing awareness about personalized medicine are fuelling the demand for genotyping. Genotyping helps in the early detection and management of genetic diseases, enabling tailored treatment plans and improving patient outcomes. This increasing need for precision medicine is a major growth driver for the market.

  • Expansion in Agricultural Genotyping:

The agriculture sector is increasingly adopting genotyping technologies to improve crop yield, resistance to diseases, and adaptation to environmental changes. This is particularly important in addressing global food security challenges. The use of genotyping in plant and animal breeding programs enhances the efficiency of selecting desirable traits, thereby boosting agricultural productivity.

Global Genotyping Market: Restraining Factors

  • High Costs of Genotyping Instruments and Reagents:

Despite technological advancements, the high initial investment required for genotyping equipment and the ongoing costs of reagents and consumables remain significant barriers. These costs can be prohibitive, especially for smaller research institutions and laboratories in developing regions, limiting the widespread adoption of genotyping technologies.

  • Stringent Regulatory Framework:

The genotyping market is subject to strict regulatory requirements to ensure the safety and efficacy of genetic tests. Navigating these complex and varying regulatory landscapes across different countries can be challenging for companies, potentially delaying product launches and increasing compliance costs, thereby restraining market growth.

Global Genotyping Market:  Opportunity Factors

  • Expansion into Emerging Markets:

Emerging markets, particularly in Asia-Pacific and Latin America, present significant growth opportunities for the genotyping market. These regions are experiencing increasing investments in healthcare infrastructure, rising awareness about genetic testing, and a growing focus on precision medicine. Companies that can effectively penetrate these markets stand to gain substantial market share.

  • Integration with Digital Health Technologies:

The integration of genotyping with digital health technologies, such as electronic health records (EHRs) and mobile health (mHealth) applications, offers immense potential. This integration can facilitate real-time data sharing, improve patient monitoring, and enhance the overall efficiency of healthcare delivery. Developing robust platforms that combine genotyping data with digital health tools can open new avenues for market growth.

Global Genotyping Market: Challenges

  • Data Privacy and Ethical Concerns:

The collection, storage, and use of genetic data raise significant privacy and ethical issues. Concerns about data security, potential misuse of genetic information, and the implications of genetic discrimination are major challenges that need to be addressed. Ensuring robust data protection measures and maintaining public trust are crucial for the sustained growth of the genotyping market.

  • Limited Skilled Workforce:

The genotyping industry requires a highly skilled workforce proficient in advanced genetic techniques and data analysis. However, there is a shortage of trained professionals in this field, which can hinder the adoption and implementation of genotyping technologies. Investing in education and training programs is essential to build a competent workforce capable of supporting the market’s growth.

Global Genotyping Market: Segmentation

Based on Product: The market is segmented into Instruments, Reagents & Kits, Software and Services.

Based on Technology: The market is segmented PCR, Capillary, Electrophoresis, Microarrays, Sequencing, Mass Spectrometry, Others.

Based on Application: The market is segmented into Pharmacogenomics, Diagnostics and Personalized Medicine, Agricultural Biotechnology, Animal Genetics, Others.

Based on End Use: The market is segmented into Pharmaceutical and Biopharmaceutical Companies, Diagnostics and Research Laboratories, Academic Institutes, Others.

Global Genotyping Market: Regional Insights

  • North America:

The North American genotyping market is growing rapidly owing to advances in technology and lower DNA sequencing prices. A new study found that sequencing can detect SARS-CoV-2 mutations about seven days sooner than conventional methods, emphasising its importance in responding to a pandemic. The pharmacogenomics business is expanding due to a growing pipeline of personalised drugs and novel drug delivery technologies that use SNPs. Genotyping is has numerous uses in pharmacogenomics, diagnostic studies, personalised medicine, and forensics, with significant implications for human diagnoses. However, managing the enormous amount of information created remains difficult, requiring large genomic databases to improve data handling. In addition, the relevance of sequencing projects and the need for bioinformatics solutions are driving the market. Partnerships like the one between QIAGEN and Freenome for NGS-based precision medicine assays exemplify the sector’s dynamic advancements.

  • Asia Pacific:

The Asia Pacific genotyping industry is rapidly expanding, owing to advances in genomic research, personalised treatment, and increased awareness of genetic illnesses. Key drivers include the increased prevalence of chronic diseases, government measures to stimulate genetic research, and technological advancements in genotyping platforms. Countries such as China, Japan, and India are leading the market due to significant expenditures in healthcare infrastructure and R&D. The market is divided into three technologies: PCR, sequencing, and microarrays, with PCR dominant due to its cost-effectiveness and efficiency. Furthermore, the increasing acceptance of directly to consumers genetic tests and the rise of biotechnology firms in the region are driving market growth. Yet, obstacles like as high expenditures for advanced technologies and ethical concerns about genetic data privacy persist. Overall, the Asia Pacific genotyping market is poised for robust growth, reflecting broader trends in genomic medicine and healthcare advancements.

Global Genotyping Market: Competitive Landscape

Illumina Inc.; Thermo Fisher Scientific Inc.; QIAGEN; F. Hoffmann-La Roche Ltd.; Fluidigm Corporation; Danaher Corporation; Agilent Technologies; Eurofins Scientific Inc.; GE Healthcare Inc.; Bio-Rad Laboratories Inc.

Global Genotyping Market: Recent Developments

  • On January 16, 2024, Agilent Technologies Inc. announced the release of its new automated parallel capillary electrophoresis system for protein analysis, the Agilent ProteoAnalyzer system, at the 23rd Annual PepTalk Conference held from January 16-19 in San Diego.
  • On June 19, 2024, Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, launched the ddSEQTM Single-Cell 3′ RNA-Seq Kit and the complementary Omnition v1.1 analysis software for single-cell transcriptome and gene expression research.
  • On June 24, 2024, Roche announced the launch of its new analytical units, cobas c 703 and cobas ISE neo, for the cobas pro integrated solutions in countries accepting the CE mark. The cobas pro integrated solutions is a scalable and modular diagnostic platform designed for high-volume laboratories.

Table of Content

CHAPTER 1: EXECUTIVE SUMMARY
1.1. Summary
CHAPTER 2: RESEARCH METHODOLOGY
2.1. Research Process
2.2. Primary Research
2.3. Secondary Research
2.4. Market Size Estimation
2.5. Research Methodology
2.6. Analyst Tools/Models/Techniques
2.6.1. Notations
2.7. Market Scope & Segmentation
2.8. Currency & Pricing Considered
CHAPTER 3: MARKET TRENDS
3.1. Introduction
3.2. Drivers
3.2.1. Increasing Prevalence of Genetic Disorders
3.3. Restraints
3.3.1. High Costs of Genotyping Instruments and Reagents
3.4. Opportunities
3.4.1. Integration with Digital Health Technologies
3.5. Challenges
3.5.1. Limited Skilled Workforce
3.6. Investment Feasibility Analysis
3.7. Latest Trends
CHAPTER 4: MARKET ASSESSMENT
4.1. Porters Five Forces Analysis
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitute
4.1.5. Intensity of Competitive Rivalry
4.2. Value Chain Analysis
4.3. Market Share Analysis
4.4. Impact of Key Regulations on the Market
4.5. SWOT Analysis
4.6. PESTEL Analysis
4.7. Patent Analysis
4.7.1. By Product Type
4.7.2. By Technology
4.7.3. By Application
4.7.4. By End Use
4.8. Roadmap Development
4.9. Market Lineage Outlook
4.9.1. Parent Market Outlook
4.9.2. Ancillary Market Outlook
CHAPTER 5: IMPACT OF RECESSION ON THE MARKET
5.1. Introduction
5.1.1. Short Term Impact
5.1.2. Long Term Impact
CHAPTER 6: GLOBAL GENOTYPING MARKET, BY PRODUCT TYPE
6.1. Introduction
6.1.1. Market Size & Forecast
6.1.2. Global Genotyping Market Share, By Product Type -2023 and 2031 (%)
6.2. INSTRUMENTS
6.2.1. Key market Trends, Growth Factors, and Opportunities
6.2.2. Market Size and Forecast, by Regions
6.3. REAGENTS & KITS
6.3.1. Key market Trends, Growth Factors, and Opportunities
6.3.2. Market Size and Forecast, by Regions
6.4. SOFTWARE AND SERVICES
6.4.1. Key market Trends, Growth Factors, and Opportunities
6.4.2. Market Size and Forecast, by Regions
CHAPTER 7: GLOBAL GENOTYPING MARKET, BY TECHNOLOGY
7.1. Introduction
7.1.1. Market Size & Forecast
7.1.2. Global Genotyping Market Share,By Development -2023 and 2031 (%)
7.2. PCR
7.2.1. Key market Trends, Growth Factors, and Opportunities
7.2.2. Market Size and Forecast, by Regions
7.3. CAPILLARY
7.3.1. Key market Trends, Growth Factors, and Opportunities
7.3.2. Market Size and Forecast, by Regions
7.4. ELECTROPHORESIS
7.4.1. Key market Trends, Growth Factors, and Opportunities
7.4.2. Market Size and Forecast, by Regions
CHAPTER 8: GLOBAL GENOTYPING MARKET, BY APPLICATION
8.1. Introduction
8.1.1. Market Size & Forecast
8.1.2. Genotyping Market Share, By Application -2023 and 2031 (%)
8.2. PHARMACOGENOMICS
8.2.1. Key market Trends, Growth Factors, and Opportunities
8.2.2. Market Size and Forecast, by Regions
8.3. DIAGNOSTICS AND PERSONALIZED MEDICINE
8.3.1. Key market Trends, Growth Factors, and Opportunities
8.3.2. Market Size and Forecast, by Regions
8.4. AGRICULTURAL BIOTECHNOLOGY
8.4.1. Key market Trends, Growth Factors, and Opportunities
8.4.2. Market Size and Forecast, by Regions
8.5. ANIMAL GENETICS
8.5.1. Key market Trends, Growth Factors, and Opportunities
8.5.2. Market Size and Forecast, by Regions
8.6. OTHERS
8.6.1. Key market Trends, Growth Factors, and Opportunities
8.6.2. Market Size and Forecast, by Regions
CHAPTER 9: GLOBAL GENOTYPING MARKET, BY END USE
9.1. Introduction
9.1.1. Market Size & Forecast
9.1.2. Global Genotyping Market Share, By End Use -2023 and 2031 (%)
9.2. PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
9.2.1. Key market Trends, Growth Factors, and Opportunities
9.2.2. Market Size and Forecast, by Regions
9.3. DIAGNOSTICS AND RESEARCH LABORATORIES
9.3.1. Key market Trends, Growth Factors, and Opportunities
9.3.2. Market Size and Forecast, by Regions
9.4. ACADEMIC INSTITUTES
9.4.1. Key market Trends, Growth Factors, and Opportunities
9.4.2. Market Size and Forecast, by Regions
CHAPTER 10: NORTH AMERICA MARKET ANALYSIS
10.1. Introduction
10.2. Genotyping Market by Country
10.3. North America Genotyping Market by Country, USD Million 2019-2031
10.3.1. Market Size & Forecast, By Product Type
10.3.2. Market Size & Forecast, By Technology
10.3.3. Market Size & Forecast, By Application
10.3.4. Market Size & Forecast, By End Use
10.4. U.S.
10.4.1. Market Size & Forecast, By Product Type
10.4.2. Market Size & Forecast, By Technology
10.4.3. Market Size & Forecast, By Application
10.4.4. Market Size & Forecast, By End Use
10.5. Canada
10.5.1. Market Size & Forecast, By Product Type
10.5.2. Market Size & Forecast, By Technology
10.5.3. Market Size & Forecast, By Application
10.5.4. Market Size & Forecast, By End Use
CHAPTER 11: EUROPE MARKET ANALYSIS
11.1. Introduction
11.2. Genotyping Market by Country
11.3. Europe Genotyping Market by Country, USD Million 2019-2031
11.3.1. Market Size & Forecast, By Product Type
11.3.2. Market Size & Forecast, By Technology
11.3.3. Market Size & Forecast, By Application
11.3.4. Market Size & Forecast, By End Use
11.4. Germany
11.4.1. Market Size & Forecast, By Product Type
11.4.2. Market Size & Forecast, By Technology
11.4.3. Market Size & Forecast, By Application
11.4.4. Market Size & Forecast, By End Use
11.5. France
11.5.1. Market Size & Forecast, By Product Type
11.5.2. Market Size & Forecast, By Technology
11.5.3. Market Size & Forecast, By Application
11.5.4. Market Size & Forecast, By End Use
11.6. U.K.
11.6.1. Market Size & Forecast, By Product Type
11.6.2. Market Size & Forecast, By Technology
11.6.3. Market Size & Forecast, By Application
11.6.4. Market Size & Forecast, By End Use
11.7. Italy
11.7.1. Market Size & Forecast, By Product Type
11.7.2. Market Size & Forecast, By Technology
11.7.3. Market Size & Forecast, By Application
11.7.4. Market Size & Forecast, By End Use
11.8. Spain
11.8.1. Market Size & Forecast, By Product Type
11.8.2. Market Size & Forecast, By Technology
11.8.3. Market Size & Forecast, By Application
11.8.4. Market Size & Forecast, By End Use
11.9. Benelux
11.9.1. Market Size & Forecast, By Product Type
11.9.2. Market Size & Forecast, By Technology
11.9.3. Market Size & Forecast, By Application
11.9.4. Market Size & Forecast, By End Use
11.10. Rest of Europe
11.10.1. Market Size & Forecast, By Product Type
11.10.2. Market Size & Forecast, By Technology
11.10.3. Market Size & Forecast, By Application
11.10.4. Market Size & Forecast, By End Use
CHAPTER 12: ASIA-PACIFIC MARKET ANALYSIS
12.1. Introduction
12.2. Genotyping Market by Country
12.3. Asia Pacific Genotyping Market by Country, USD Million 2019-2031
12.3.1. Market Size & Forecast, By Product Type
12.3.2. Market Size & Forecast, By Technology
12.3.3. Market Size & Forecast, By Application
12.3.4. Market Size & Forecast, By End Use
12.4. China
12.4.1. Market Size & Forecast, By Product Type
12.4.2. Market Size & Forecast, By Technology
12.4.3. Market Size & Forecast, By Application
12.4.4. Market Size & Forecast, By End Use
12.5. India
12.5.1. Market Size & Forecast, By Product Type
12.5.2. Market Size & Forecast, By Technology
12.5.3. Market Size & Forecast, By Application
12.5.4. Market Size & Forecast, By End Use
12.6. Japan
12.6.1. Market Size & Forecast, By Product Type
12.6.2. Market Size & Forecast, By Technology
12.6.3. Market Size & Forecast, By Application
12.6.4. Market Size & Forecast, By End Use
12.7. Australia
12.7.1. Market Size & Forecast, By Product Type
12.7.2. Market Size & Forecast, By Technology
12.7.3. Market Size & Forecast, By Application
12.7.4. Market Size & Forecast, By End Use
12.8. South Korea
12.8.1. Market Size & Forecast, By Product Type
12.8.2. Market Size & Forecast, By Technology
12.8.3. Market Size & Forecast, By Application
12.8.4. Market Size & Forecast, By End Use
12.9. Souethest Asia
12.9.1. Market Size & Forecast, By Product Type
12.9.2. Market Size & Forecast, By Technology
12.9.3. Market Size & Forecast, By Application
12.9.4. Market Size & Forecast, By End Use
12.10. Rest of Asia Pacific
12.10.1. Market Size & Forecast, By Product Type
12.10.2. Market Size & Forecast, By Technology
12.10.3. Market Size & Forecast, By Application
12.10.4. Market Size & Forecast, By End Use
CHAPTER 13: LATIN AMERICA AND THE CARIBBEAN MARKET ANALYSIS
13.1. Introduction
13.2. Genotyping Market by Country
13.3. Latin America Genotyping Market by Country, USD Million 2019-2031
13.3.1. Market Size & Forecast, By Product Type
13.3.2. Market Size & Forecast, By Technology
13.3.3. Market Size & Forecast, By Application
13.3.4. Market Size & Forecast, By End Use
13.4. Brazil
13.4.1. Market Size & Forecast, By Product Type
13.4.2. Market Size & Forecast, By Technology
13.4.3. Market Size & Forecast, By Application
13.4.4. Market Size & Forecast, By End Use
13.5. Mexico
13.5.1. Market Size & Forecast, By Product Type
13.5.2. Market Size & Forecast, By Technology
13.5.3. Market Size & Forecast, By Application
13.5.4. Market Size & Forecast, By End Use
13.6. Rest of Latin America
13.6.1. Market Size & Forecast, By Product Type
13.6.2. Market Size & Forecast, By Technology
13.6.3. Market Size & Forecast, By Application
13.6.4. Market Size & Forecast, By End Use
CHAPTER 14: THE MIDDLE EAST AND AFRICA MARKET ANALYSIS
14.1. Introduction
14.2. Genotyping Market by Country
14.3. MEA Genotyping Market by Country, USD Million 2019-2031
14.3.1. Market Size & Forecast, By Product Type
14.3.2. Market Size & Forecast, By Technology
14.3.3. Market Size & Forecast, By Application
14.3.4. Market Size & Forecast, By End Use
14.4. South Africa
14.4.1. Market Size & Forecast, By Product Type
14.4.2. Market Size & Forecast, By Technology
14.4.3. Market Size & Forecast, By Application
14.4.4. Market Size & Forecast, By End Use
14.5. Saudi Arabia
14.5.1. Market Size & Forecast, By Product Type
14.5.2. Market Size & Forecast, By Technology
14.5.3. Market Size & Forecast, By Application
14.5.4. Market Size & Forecast, By End Use
14.6. UAE
14.6.1. Market Size & Forecast, By Product Type
14.6.2. Market Size & Forecast, By Technology
14.6.3. Market Size & Forecast, By Application
14.6.4. Market Size & Forecast, By End Use
14.7. Rest of MEA
14.7.1. Market Size & Forecast, By Product Type
14.7.2. Market Size & Forecast, By Technology
14.7.3. Market Size & Forecast, By Application
14.7.4. Market Size & Forecast, By End Use
CHAPTER 15: COMPETITIVE LANDSCAPE
15.1. Introduction
15.2. Market Player Positioning, 2022
15.3. Company Evaluation Matrix
15.4. Product Mapping of Top 10 Player
15.5. Market Opportunities and Future Trends
15.6. Competitive Heatmap
15.7. Top Winning Growth Strategies
15.7.1. Major Growth Strategies
15.7.2. Expansion
15.7.3. Merger and Acquisition
15.7.4. Other Developments
CHAPTER 16: COMPANY PROFILES
16.1. ILLUMINA INC.
16.1.1. Company Overview
16.1.2. Key Executives
16.1.3. Financial Overview
16.1.4. Business Offeringnalysis
16.1.5. Product Portfolio
16.1.6. Key Strategic Developments
16.2. THERMO FISHER SCIENTIFIC INC.
16.3. QIAGEN
16.4. F. HOFFMANN-LA ROCHE LTD.
16.5. FLUIDIGM CORPORATION
16.6. DANAHER CORPORATION
16.7. AGILENT TECHNOLOGIES
16.8. EUROFINS SCIENTIFIC INC.
16.9. GE HEALTHCARE INC.
16.10. BIO-RAD LABORATORIES INC.

Tables & Figures

LIST OF TABLES
Table 1. Global Genotyping Market INDUSTRY SNAPSHOT, 2022-2031
Table 2. Global Genotyping Market SHARE, By Product Type -2019-2031 (USD MILLION)
Table 3. Global Genotyping Market INSTRUMENTS, BY REGION-2019-2031 (USD MILLION)
Table 4. Global Genotyping Market REAGENTS & KITS, BY REGION-2019-2031 (USD MILLION)
Table 5. Global Genotyping Market SOFTWARE AND SERVICES, BY REGION-2019-2031 (USD MILLION)
Table 6. Global Genotyping Market SHARE, By Technology-2019-2031 (USD MILLION)
Table 7. Global Genotyping Market PCR, BY REGION-2019-2031 (USD MILLION)
Table 8. Global Genotyping Market CAPILLARY, BY REGION-2019-2031 (USD MILLION)
Table 9. Global Genotyping Market ELECTROPHORESIS, BY REGION-2019-2031 (USD MILLION)
Table 10. Global Genotyping Market SEQUENCING, BY REGION-2019-2031 (USD MILLION)
Table 11. Global Genotyping Market MASS SPECTROMETRY, BY REGION-2019-2031 (USD MILLION)
Table 12. Global Genotyping Market OTHERS, BY REGION-2019-2031 (USD MILLION)
Table 13. Global Genotyping Market SHARE, By Application -2019-2031 (USD MILLION)
Table 14. Global Genotyping Market PHARMACOGENOMICS, BY REGION-2019-2031 (USD MILLION)
Table 15. Global Genotyping Market DIAGNOSTICS AND PERSONALIZED MEDICINE, BY REGION-2019-2031 (USD MILLION)
Table 16. Global Genotyping Market AGRICULTURAL BIOTECHNOLOGY, BY REGION-2019-2031 (USD MILLION)
Table 17. Global Genotyping Market FOR ANIMAL GENETICS BY REGION-2019-2031 (USD MILLION)
Table 18. Global Genotyping Market FOR OTHERS BY REGION-2019-2031 (USD MILLION)
Table 19. NORTH AMERICA Genotyping Market BY COUNTRY, USD MILLION 2019-2031
Table 20. NORTH AMERICA Genotyping Market SHARE, By Product Type -2019-2031 (USD MILLION)
Table 21. NORTH AMERICA Genotyping Market SHARE, By Technology -2019-2031 (USD MILLION)
Table 22. NORTH AMERICA Genotyping Market SHARE, By Application – 2019-2031 (USD MILLION)
Table 23. NORTH AMERICA Genotyping Market SHARE, By End Use -2019-2031 (USD MILLION)
Table 24. U.S. Genotyping Market SHARE, By Product Type -2019-2031 (USD MILLION)
Table 25. U.S. Genotyping Market SHARE, By Technology -2019-2031 (USD MILLION)
Table 26. U.S. Genotyping Market SHARE, By Application – 2019-2031 (USD MILLION)
Table 27. U.S. Genotyping Market SHARE, By End Use -2019-2031 (USD MILLION)
Table 28. CANADA Genotyping Market SHARE, By Product Type -2019-2031 (USD MILLION)
Table 29. CANADA Genotyping Market SHARE, By Technology -2019-2031 (USD MILLION)
Table 30. CANADA Genotyping Market SHARE, By Application – 2019-2031 (USD MILLION)
Table 31. CANADA Genotyping Market SHARE, By End Use -2019-2031 (USD MILLION)
Table 32. EUROPE Genotyping Market BY COUNTRY, USD MILLION 2019-2031
Table 33. EUROPE Genotyping Market SHARE, By Product Type -2019-2031 (USD MILLION)
Table 34. EUROPE Genotyping Market SHARE, By Technology -2019-2031 (USD MILLION)
Table 35. EUROPE Genotyping Market SHARE, By Application – 2019-2031 (USD MILLION)
Table 36. EUROPE Genotyping Market SHARE, By End Use -2019-2031 (USD MILLION)
Table 37. GERMANY Genotyping Market SHARE, By Product Type -2019-2031 (USD MILLION)
Table 38. GERMANY Genotyping Market SHARE, By Technology -2019-2031 (USD MILLION)
Table 39. GERMANY Genotyping Market SHARE, By Application – 2019-2031 (USD MILLION)
Table 40. GERMANY Genotyping Market SHARE, By End Use -2019-2031 (USD MILLION)
Table 41. FRANCE Genotyping Market SHARE, By Product Type -2019-2031 (USD MILLION)
Table 42. FRANCE Genotyping Market SHARE, By Technology -2019-2031 (USD MILLION)
Table 43. FRANCE Genotyping Market SHARE, By Application – 2019-2031 (USD MILLION)
Table 44. FRANCE Genotyping Market SHARE, By End Use -2019-2031 (USD MILLION)
Table 45. UK Genotyping Market SHARE, By Product Type -2019-2031 (USD MILLION)
Table 46. UK Genotyping Market SHARE, By Technology -2019-2031 (USD MILLION)
Table 47. UK Genotyping Market SHARE, By Application – 2019-2031 (USD MILLION)
Table 48. UK Genotyping Market SHARE, By End Use -2019-2031 (USD MILLION)
Table 49. ITALY Genotyping Market SHARE, By Product Type -2019-2031 (USD MILLION)
Table 50. ITALY Genotyping Market SHARE, By Technology -2019-2031 (USD MILLION)
Table 51. ITALY Genotyping Market SHARE, By Application – 2019-2031 (USD MILLION)
Table 52. ITALY Genotyping Market SHARE, By End Use -2019-2031 (USD MILLION)
Table 53. SPAIN Genotyping Market SHARE, By Product Type -2019-2031 (USD MILLION)
Table 54. SPAIN Genotyping Market SHARE, By Technology -2019-2031 (USD MILLION)
Table 55. SPAIN Genotyping Market SHARE, By Application – 2019-2031 (USD MILLION)
Table 56. SPAIN Genotyping Market SHARE, By End Use -2019-2031 (USD MILLION)
Table 57. BENELUX Genotyping Market SHARE, By Product Type -2019-2031 (USD MILLION)
Table 58. BENELUX Genotyping Market SHARE, By Technology -2019-2031 (USD MILLION)
Table 59. BENELUX Genotyping Market SHARE, By Application – 2019-2031 (USD MILLION)
Table 60. BENELUX Genotyping Market SHARE, By End Use -2019-2031 (USD MILLION)
Table 61. REST OF EUROPE Genotyping Market SHARE, By Product Type -2019-2031 (USD MILLION)
Table 62. REST OF EUROPE Genotyping Market SHARE, By Technology -2019-2031 (USD MILLION)
Table 63. REST OF EUROPE Genotyping Market SHARE, By Application – 2019-2031 (USD MILLION)
Table 64. REST OF EUROPE Genotyping Market SHARE, By End Use -2019-2031 (USD MILLION)
Table 65. ASIA PACIFIC Genotyping Market BY COUNTRY, USD MILLION 2019-2031
Table 66. ASIA PACIFIC Genotyping Market SHARE, By Product Type -2019-2031 (USD MILLION)
Table 67. ASIA PACIFIC Genotyping Market SHARE, By Technology -2019-2031 (USD MILLION)
Table 68. ASIA PACIFIC Genotyping Market SHARE, By Application – 2019-2031 (USD MILLION)
Table 69. ASIA PACIFIC Genotyping Market SHARE, By End Use -2019-2031 (USD MILLION)
Table 70. CHINA Genotyping Market SHARE, By Product Type -2019-2031 (USD MILLION)
Table 71. CHINA Genotyping Market SHARE, By Technology -2019-2031 (USD MILLION)
Table 72. CHINA Genotyping Market SHARE, By Application – 2019-2031 (USD MILLION)
Table 73. CHINA Genotyping Market SHARE, By End Use -2019-2031 (USD MILLION)
Table 74. INDIA Genotyping Market SHARE, By Product Type -2019-2031 (USD MILLION)
Table 75. INDIA Genotyping Market SHARE, By Technology -2019-2031 (USD MILLION)
Table 76. INDIA Genotyping Market SHARE, By Application – 2019-2031 (USD MILLION)
Table 77. INDIA Genotyping Market SHARE, By End Use -2019-2031 (USD MILLION)
Table 78. JAPAN Genotyping Market SHARE, By Product Type -2019-2031 (USD MILLION)
Table 79. JAPAN Genotyping Market SHARE, By Technology -2019-2031 (USD MILLION)
Table 80. JAPAN Genotyping Market SHARE, By Application – 2019-2031 (USD MILLION)
Table 81. JAPAN Genotyping Market SHARE, By End Use -2019-2031 (USD MILLION)
Table 82. AUSTRALIA Genotyping Market SHARE, By Product Type -2019-2031 (USD MILLION)
Table 83. AUSTRALIA Genotyping Market SHARE, By Technology -2019-2031 (USD MILLION)
Table 84. AUSTRALIA Genotyping Market SHARE, By Application – 2019-2031 (USD MILLION)
Table 85. AUSTRALIA Genotyping Market SHARE, By End Use -2019-2031 (USD MILLION)
Table 86. SOUTH KOREA Genotyping Market SHARE, By Product Type -2019-2031 (USD MILLION)
Table 87. SOUTH KOREA Genotyping Market SHARE, By Technology -2019-2031 (USD MILLION)
Table 88. SOUTH KOREA Genotyping Market SHARE, By Application – 2019-2031 (USD MILLION)
Table 89. SOUTH KOREA Genotyping Market SHARE, By End Use -2019-2031 (USD MILLION)
Table 90. SOUETHEST ASIA Genotyping Market SHARE, By Product Type -2019-2031 (USD MILLION)
Table 91. SOUETHEST ASIA Genotyping Market SHARE, By Technology -2019-2031 (USD MILLION)
Table 92. SOUETHEST ASIA Genotyping Market SHARE, By Application – 2019-2031 (USD MILLION)
Table 93. SOUETHEST ASIA Genotyping Market SHARE, By End Use -2019-2031 (USD MILLION)
Table 94. REST OF ASIA PACIFIC Genotyping Market SHARE, By Product Type -2019-2031 (USD MILLION)
Table 95. REST OF ASIA PACIFIC Genotyping Market SHARE, By Technology -2019-2031 (USD MILLION)
Table 96. REST OF ASIA PACIFIC Genotyping Market SHARE, By Application – 2019-2031 (USD MILLION)
Table 97. REST OF ASIA PACIFIC Genotyping Market SHARE, By End Use -2019-2031 (USD MILLION)
Table 98. LATIN AMERICA Genotyping Market BY COUNTRY, USD MILLION 2019-2031
Table 99. LATIN AMERICA Genotyping Market SHARE, By Product Type -2019-2031 (USD MILLION)
Table 100. LATIN AMERICA Genotyping Market SHARE, By Technology -2019-2031 (USD MILLION)
Table 101. LATIN AMERICA Genotyping Market SHARE, By Application – 2019-2031 (USD MILLION)
Table 102. LATIN AMERICA Genotyping Market SHARE, By End Use -2019-2031 (USD MILLION)
Table 103. BRAZIL Genotyping Market SHARE, By Product Type -2019-2031 (USD MILLION)
Table 104. BRAZIL Genotyping Market SHARE, By Technology -2019-2031 (USD MILLION)
Table 105. BRAZIL Genotyping Market SHARE, By Application – 2019-2031 (USD MILLION)
Table 106. BRAZIL Genotyping Market SHARE, By End Use -2019-2031 (USD MILLION)
Table 107. MEXICO Genotyping Market SHARE, By Product Type -2019-2031 (USD MILLION)
Table 108. MEXICO Genotyping Market SHARE, By Technology -2019-2031 (USD MILLION)
Table 109. MEXICO Genotyping Market SHARE, By Application – 2019-2031 (USD MILLION)
Table 110. MEXICO Genotyping Market SHARE, By End Use -2019-2031 (USD MILLION)
Table 111. REST OF LATIN AMERICA Genotyping Market SHARE, By Product Type -2019-2031 (USD MILLION)
Table 112. REST OF LATIN AMERICA Genotyping Market SHARE, By Technology -2019-2031 (USD MILLION)
Table 113. REST OF LATIN AMERICA Genotyping Market SHARE, By Application – 2019-2031 (USD MILLION)
Table 114. REST OF LATIN AMERICA Genotyping Market SHARE, By End Use -2019-2031 (USD MILLION)
Table 115. MEA Genotyping Market BY COUNTRY, USD MILLION 2019-2031
Table 116. MEA Genotyping Market SHARE, By Product Type -2019-2031 (USD MILLION)
Table 117. MEA Genotyping Market SHARE, By Technology -2019-2031 (USD MILLION)
Table 118. MEA Genotyping Market SHARE, By Application – 2019-2031 (USD MILLION)
Table 119. MEA Genotyping Market SHARE, By End Use -2019-2031 (USD MILLION)
Table 120. SOUTH AFRICA Genotyping Market SHARE, By Product Type -2019-2031 (USD MILLION)
Table 121. SOUTH AFRICA Genotyping Market SHARE, By Technology -2019-2031 (USD MILLION)
Table 122. SOUTH AFRICA Genotyping Market SHARE, By Application – 2019-2031 (USD MILLION)
Table 123. SOUTH AFRICA Genotyping Market SHARE, By End Use -2019-2031 (USD MILLION)
Table 124. SAUDI ARABIA Genotyping Market SHARE, By Product Type -2019-2031 (USD MILLION)
Table 125. SAUDI ARABIA Genotyping Market SHARE, By Technology -2019-2031 (USD MILLION)
Table 126. SAUDI ARABIA Genotyping Market SHARE, By Application – 2019-2031 (USD MILLION)
Table 127. SAUDI ARABIA Genotyping Market SHARE, By End Use -2019-2031 (USD MILLION)
Table 128. UAE Genotyping Market SHARE, By Product Type -2019-2031 (USD MILLION)
Table 129. UAE Genotyping Market SHARE, By Technology -2019-2031 (USD MILLION)
Table 130. UAE Genotyping Market SHARE, By Application – 2019-2031 (USD MILLION)
Table 131. UAE Genotyping Market SHARE, By End Use -2019-2031 (USD MILLION)
Table 132. REST OF MEA Genotyping Market SHARE, By Product Type -2019-2031 (USD MILLION)
Table 133. REST OF MEA Genotyping Market SHARE, By Technology -2019-2031 (USD MILLION)
Table 134. REST OF MEA Genotyping Market SHARE, By Application – 2019-2031 (USD MILLION)
Table 135. REST OF MEA Genotyping Market SHARE, By End Use -2019-2031 (USD MILLION)
Table 136. KEY EXPANSIONS (2019-2022)
Table 137. KEY MERGERS AND ACQUISITION (2019-2022)
Table 138. OTHER KEY DEVELOPMENTS (2019-2022)

LIST OF FIGURES
Figure 1. REGIONAL ANALYSIS (2022 & 2031)
Figure 2. RESEARCH PROCESS
Figure 3. ANALYSIS FRAMEWORK
Figure 4. IMPACT OF KEY REGULATION ON THE MARKET
Figure 5. SWOT ANALYSIS
Figure 6. Global Genotyping Market SHARE, By Product Type -2023 & 2031 (USD MILLION)
Figure 7. Global Genotyping Market , INSTRUMENTS -2019-2031 (USD MILLION)
Figure 8. Global Genotyping Market , REAGENTS & KITS -2019-2031 (USD MILLION)
Figure 9. Global Genotyping Market , SOFTWARE AND SERVICES-2019-2031 (USD MILLION)
Figure 10. Global Genotyping Market SHARE, By Technology -2023 & 2031 (USD MILLION)
Figure 11. Global Genotyping Market , PCR -2019-2031 (USD MILLION)
Figure 12. Global Genotyping Market , CAPILLARY -2019-2031 (USD MILLION)
Figure 13. Global Genotyping Market , ELECTROPHORESIS -2019-2031 (USD MILLION)
Figure 14. Global Genotyping Market , MICROARRAYS -2019-2031 (USD MILLION)
Figure 15. Global Genotyping Market , SEQUENCING -2019-2031 (USD MILLION)
Figure 16. Global Genotyping Market , MASS SPECTROMETRY -2019-2031 (USD MILLION)
Figure 17. Global Genotyping Market SHARE, By Application -2023 & 2031 (USD MILLION)
Figure 18. Global Genotyping Market , PHARMACOGENOMICS -2019-2031 (USD MILLION)
Figure 19. Global Genotyping Market , DIAGNOSTICS AND PERSONALIZED MEDICINE -2019-2031 (USD MILLION)
Figure 20. Global Genotyping Market , AGRICULTURAL BIOTECHNOLOGY -2019-2031 (USD MILLION)
Figure 21. Global Genotyping Market , ANIMAL GENETICS -2019-2031 (USD MILLION)
Figure 22. Global Genotyping Market SHARE, By End Use -2023 & 2031 (USD MILLION)
Figure 23. Global Genotyping Market , PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES -2019-2031 (USD MILLION)
Figure 24. Global Genotyping Market , DIAGNOSTICS AND RESEARCH LABORATORIES -2019-2031 (USD MILLION)
Figure 25. Global Genotyping Market , ACADEMIC INSTITUTES -2019-2031 (USD MILLION)
Figure 26. Global Genotyping Market , OTHERS -2019-2031 (USD MILLION)
Figure 27. MARKET PLAYER POSITIONING, 2022
Figure 28. COMPANY EVALUATION MATRIX
Figure 29. PRODUCT MAPPING OF TOP 10 PLAYERS
Figure 30. COMPETITIVE HEATMAP OF KEY PLAYERS

Frequently Asked Questions (FAQ):

  • Which is the leading segment in the Global Genotyping Market?

    The Sequencing technology segment is currently the dominating segment.
  • What are the key factors driving the Global Genotyping Market?

    Improvements in genotyping technologies, Rising Awareness and Adoption of Genetic Testing are some of the key factors driving the growth in the market.
  • Which region will contribute notably towards the Global Genotyping Market?

    North America region to contribute the major share towards the market growth.
  • What are the key players in the Global Genotyping Market?

    Illumina Inc.; Thermo Fisher Scientific Inc.; QIAGEN; F. Hoffmann-La Roche Ltd.; Fluidigm Corporation; Danaher Corporation; Agilent Technologies; Eurofins Scientific Inc.; GE Healthcare Inc.; Bio-Rad Laboratories Inc. and Others.

Buying Options

Original price was: $6,000.00.Current price is: $5,100.00.
Original price was: $5,000.00.Current price is: $4,500.00.
Original price was: $4,000.00.Current price is: $3,800.00.